RadNet, Inc. (RDNT)

$17.93

+0.73 (+4.24%)
Rating:
Recommendation:
Strong Buy
Symbol RDNT
Price $17.93
Beta 1.748
Volume Avg. 0.24M
Market Cap 1.028B
Shares () -
52 Week Range 16.44-34.69
1y Target Est -
DCF Unlevered RDNT DCF ->
DCF Levered RDNT LDCF ->
ROE 14.52% Buy
ROA 1.91% Neutral
Operating Margin -
Debt / Equity 573.17% Strong Buy
P/E 44.83 Strong Buy
P/B 3.22 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest RDNT news


Dr. Howard Berger
Healthcare
Diagnostics & Research
NASDAQ Global Market

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.